Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Koyama
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression Upon Drug Administration
Cancer immunology research
Cancer Research
Immunology
Related publications
169. Clinically Adaptable CD19-Specific Chimeric Antigen Receptor
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
Characterization of Clinical Grade CD19 Chimeric Antigen Receptor T Cells Produced Using Automated CliniMACS Prodigy System
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy
British Journal of Haematology
Hematology
Haemophagocytic Lymphohistiocytosis Has Variable Time to Onset Following CD19 Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology
Hematology
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
74. The Impact of Different Hinge and Transmembrane Components on the Function of a Novel Fully-Human Anti-Cd19 Chimeric Antigen Receptor
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology